Subtype
Malignant Female Reproductive System Neoplasm
CI-CAN-00003157Explore in graph →
1,464 active trials11 approved drugs128 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003157Explore in graph →
Clinical trials
6,254 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (740)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05242276 | Uterine Manipulator in Endometrial Cancer Surgery: Pro MUCEI Study(proMUCEI) | unknown | — | 1,200 | Instituto de Investigacion Sanitaria La FeOTHER | 1 | Oct 10, 2023 | clinicaltrials |
| NCT06068387 | A Prospective Study on the Prediction Model of Para-aortic Lymph Node Metastasis | unknown | N/A | 264 | Chongqing University Cancer HospitalOTHER | 1 | Oct 10, 2023 |
| clinicaltrials |
| NCT03876860 | An Enhanced Vaginal Dilator to Reduce Radiation-Induced Vaginal Stenosis | unknown | N/A | 118 | Margaret LiottaOTHER | 1 | Oct 5, 2023 | clinicaltrials |
| NCT05272462 | Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian Cancer | unknown | Phase 2 | 34 | Loyola UniversityOTHER | 1 | Oct 5, 2023 | clinicaltrials |
| NCT06015360 | Fat Grafting for Vaginal Stenosis in Gynaelogical Cancer(GRASS) | unknown | N/A | 8 | Royal Marsden NHS Foundation TrustOTHER | 1 | Oct 5, 2023 | clinicaltrials |
| NCT06001099 | PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale Cancers, PERCEIVE-II | unknown | — | 2,935 | Fudan UniversityOTHER | 1 | Sep 29, 2023 | clinicaltrials |
| NCT00923702 | Trial of Two Versus Three Doses of Human Papillomavirus (HPV) Vaccine in India | unknown | Phase 4 | 22,729 | Partha BasuOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT03382340 | IMX-110 in Patients With Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 70 | Immix Biopharma Australia Pty LtdINDUSTRY | 2 | Sep 28, 2023 | clinicaltrials |
| NCT05926336 | The Effects of Using Different Anesthetics on the Prognosis of Primary Tumors and Its Mechanism of Action | unknown | Phase 4 | 1,316 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT06055348 | SC0191 Plus Chemotherapy in Advanced Ovarian Canceradvanced Ovarian Cancer | unknown | Phase 1 / Phase 2 | 112 | Biocity Biopharmaceutics Co., Ltd.INDUSTRY | 0 | Sep 26, 2023 | clinicaltrials |
| NCT04492995 | Sentinel Node in Endometrial Cancer(HYBRIDENDONOD) | unknown | Phase 2 | 70 | Judit Pich MartínezOTHER | 1 | Sep 18, 2023 | clinicaltrials |
| NCT02495311 | The Association Between Adenomyosis/Uterine Myoma and Lower Urinary Tract Symptoms | unknown | — | 150 | Far Eastern Memorial HospitalOTHER | 1 | Sep 15, 2023 | clinicaltrials |
| NCT03931265 | Ketohexokinase Isoforms in Endometrial Cancer. | unknown | — | 220 | Far Eastern Memorial HospitalOTHER | 1 | Sep 15, 2023 | clinicaltrials |
| NCT04414683 | Factors Affecting the Prognosis of Early Ovarian Cancer | unknown | — | 300 | Far Eastern Memorial HospitalOTHER | 1 | Sep 15, 2023 | clinicaltrials |
| NCT06037213 | A Real-World Patient-Reported Outcomes Study in Patients With Long-Term Use of Niraparib | unknown | — | 500 | Peking Union Medical College HospitalOTHER | 1 | Sep 14, 2023 | clinicaltrials |
| NCT04311073 | Prophylactic Tranexamic Acid During Minimally Invasive Myomectomies | unknown | Phase 3 | 50 | Eastern Virginia Medical SchoolOTHER | 1 | Sep 11, 2023 | clinicaltrials |
| NCT05313724 | Mind-body Online Therapy in Gynecological Oncology | unknown | N/A | 120 | Katja Haemmerli KellerOTHER | 1 | Sep 6, 2023 | clinicaltrials |
| NCT06025045 | Dynamic Monitoring of ctDNA Predicts Recurrence of Advanced Ovarian Cancer After Primary Treatments | unknown | — | 50 | Jing LiOTHER | 1 | Sep 6, 2023 | clinicaltrials |
| NCT06020924 | The Effects of Uterine Fibroids on Pregnancy in Women | unknown | — | 1,658 | Wenwen WangOTHER | 1 | Sep 1, 2023 | clinicaltrials |
| NCT04768270 | The Culture of Ovarian Cancer Organoids and Drug Screening | unknown | — | 30 | Chongqing University Cancer HospitalOTHER | 1 | Aug 31, 2023 | clinicaltrials |
| NCT05805358 | Hyperpolarized 13C MRI for Cancer Immunotherapy(DNPSPIO) | unknown | Phase 2 | 90 | Chang Gung Memorial HospitalOTHER | 1 | Aug 30, 2023 | clinicaltrials |
| NCT06016868 | Identification of a MOLecuLar Signature in Locally Advanced Cervical Cancer Patients(MOLLY) | unknown | — | 25 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Aug 30, 2023 | clinicaltrials |
| NCT06009562 | Management of Symptomatic Uterine Fibroids in Pregnancy by Laparotomic Myomectomy: a Prospective Cohort Study(LPTM-UFs-P) | unknown | — | 28 | University of PalermoOTHER | 1 | Aug 24, 2023 | clinicaltrials |
| NCT06010667 | A Prospective, Randomized Controlled Study of Cyclophosphamide, Bevacizumab With or Without Envafolimab in Recurrent Epithelial Ovarian Cancer (EOC), Fallopian Tube Cancer, and Primary Peritoneal Cancer | unknown | — | 60 | Hebei Medical University Fourth HospitalOTHER | 1 | Aug 24, 2023 | clinicaltrials |
| NCT06007625 | Vulvar Cancer Individualized Scoring System (VCISS) | unknown | — | 1,000 | Assiut UniversityOTHER | 1 | Aug 23, 2023 | clinicaltrials |
| NCT05420545 | A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors | unknown | Phase 1 | 36 | Chongqing Precision Biotech Co., LtdINDUSTRY | 1 | Aug 18, 2023 | clinicaltrials |
| NCT05468190 | A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T | unknown | Phase 1 | 48 | Chongqing Precision Biotech Co., LtdINDUSTRY | 1 | Aug 18, 2023 | clinicaltrials |
| NCT05856409 | Clinical Application of 68Ga-FAPI PET Imaging in Detection of Ovarian Cancer Recurrence | unknown | — | 20 | RenJi HospitalOTHER | 1 | Aug 16, 2023 | clinicaltrials |
| NCT03363867 | BEACON - ABC in Recurrent Platinum Resistant HGSOC(BEACON) | unknown | Phase 2 | 30 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | Aug 7, 2023 | clinicaltrials |
| NCT05976113 | A Retrospective Study on Multiple Classifier Endometrial Cancer | unknown | — | 80 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Aug 4, 2023 | clinicaltrials |
| NCT05976932 | Circulating Tumor DNA Monitoring in Platinum-resistant Ovarian Cancer | unknown | — | 20 | Fudan UniversityOTHER | 0 | Aug 4, 2023 | clinicaltrials |
| NCT05318625 | A Prospective Study to Evaluate the Clinical Performance and Safety of the SIRIUS Endoscope System in Laparoscopic Gynecological Surgery. | unknown | N/A | 30 | Precision Robotics (Hong Kong) LimitedINDUSTRY | 1 | Aug 3, 2023 | clinicaltrials |
| NCT05874115 | Development of a Biomarker to Predict the Efficacy of Anti-angiogenic Therapy in Ovarian Cancer(OutCoME) | unknown | — | 75 | Centro di Riferimento Oncologico - AvianoOTHER | 1 | Aug 3, 2023 | clinicaltrials |
| NCT05969405 | Comparison of Prognosis in Endometrial Cancer Treated With Different Surgical Methods: Laparoscopy, Robotic-assisted Laparoscopy and Laparotomy | unknown | — | 400 | Far Eastern Memorial HospitalOTHER | 1 | Aug 1, 2023 | clinicaltrials |
| NCT05965141 | Aribulin Combined With Carboplatin and Bevacizumab in the Treatment of Ovarian Cancer | unknown | Phase 1 / Phase 2 | 38 | Second Affiliated Hospital of Guangzhou Medical UniversityOTHER | 0 | Jul 28, 2023 | clinicaltrials |
| NCT05078307 | Evaluation of a Hysteroscopic Method With Vaporization in the Hysteroscopic Treatment of Submucosal Uterine Fibroids(VAPOHYSTERO) | unknown | N/A | 54 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Jul 27, 2023 | clinicaltrials |
| NCT05961111 | A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors | unknown | Early Phase 1 | 20 | Shanghai Yunying Medical TechnologyINDUSTRY | 1 | Jul 27, 2023 | clinicaltrials |
| NCT05942209 | ECO-LEAK Technique: Early Detection of Colorectal Anastomotic Leakage by Transvaginal Ultrasound | unknown | — | 766 | Instituto de Investigacion Sanitaria La FeOTHER | 1 | Jul 21, 2023 | clinicaltrials |
| NCT05955079 | Circulating Tumor DNA Study in Patients With Endometrial Cancer(ctDNA-endo) | unknown | — | 130 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jul 21, 2023 | clinicaltrials |
| NCT05223218 | Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study | unknown | — | 500 | Namida LabINDUSTRY | 1 | Jul 3, 2023 | clinicaltrials |
| NCT04201561 | High Dose Inorganic Selenium for Preventing Chemotherapy Induced Peripheral Neuropathy(SELENIUM) | unknown | Phase 3 | 68 | Seoul National University HospitalOTHER | 1 | Jun 26, 2023 | clinicaltrials |
| NCT04678102 | Chk2 Inhibitor for Recurrent EpitheliAl periToneal, fallopIan or oVarian cancEr (CREATIVE Phase IA Trial)(CREATIVE) | unknown | Phase 1 | 36 | Seoul National University HospitalOTHER | 1 | Jun 26, 2023 | clinicaltrials |
| NCT04699006 | Efficacy and Adverse Effects of Olaparib in Ovarian Cancer. | unknown | — | 245 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Jun 15, 2023 | clinicaltrials |
| NCT05904977 | Preliminary Study on the Metastatic Rate and Clinical Significance of the Anterior Leaf of Vesicouterine Ligament in Early Stage Cervical Cancer | unknown | — | 460 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jun 15, 2023 | clinicaltrials |
| NCT05894915 | Study and Transformation of Tumor Molecular Features Screening Model of Endometrial Carcinoma Surgical Approach | unknown | N/A | 390 | Peking University People's HospitalOTHER | 0 | Jun 8, 2023 | clinicaltrials |
| NCT05886075 | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors | unknown | Early Phase 1 | 24 | Shanghai Yunying Medical TechnologyINDUSTRY | 1 | Jun 2, 2023 | clinicaltrials |
| NCT04631731 | Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity(ICEMELT) | unknown | Phase 1 / Phase 2 | 200 | Western Sydney Local Health DistrictOTHER | 1 | Jun 1, 2023 | clinicaltrials |
| NCT05883670 | Real-world Study of Serplulimab in 2L and Above Treatment of Cervical Cancer | unknown | — | 118 | Shandong UniversityOTHER | 1 | Jun 1, 2023 | clinicaltrials |
| NCT05881967 | Molecular Mechanism Study of Uterine Sarcoma | unknown | — | 300 | Shixuan WangOTHER | 1 | May 31, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Oct 10, 2023source: clinicaltrials